drugset
drugset / Trial / NCT05069350

Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

NCT05069350 ↗

Phase 0 Completed 100 enrolled Research Institute of Ophthalmology, Egypt
RandomizedParallel-groupTriple-blindPrevention

Summary

comparing two local anaesthetic agents, Bupivacaine 0.5% versus Oxybuprocaine used topically to provide surface anaesthesia before IVI procedures.

Timeline

Start
2021-09-01
Primary completion
2022-08-01
Completion
2022-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Topical
Subject bupivacaine 0.5% and oxubuprocaine Unknown — Topical

Indications

No indication recorded.